- Home
- TUYA vs ANIP Comparison
TUYA vs ANIP Comparison
Compare TUYA & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TUYA
- ANIP
- Stock Information
- Founded
- TUYA 2014
- ANIP 2001
- Country
- TUYA China
- ANIP United States
- Employees
- TUYA N/A
- ANIP N/A
- Industry
- TUYA Computer Software: Prepackaged Software
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- TUYA Technology
- ANIP Health Care
- Exchange
- TUYA Nasdaq
- ANIP Nasdaq
- Market Cap
- TUYA 1.5B
- ANIP 1.2B
- IPO Year
- TUYA 2021
- ANIP N/A
- Fundamental
- Price
- TUYA $4.07
- ANIP $57.94
- Analyst Decision
- TUYA
- ANIP Buy
- Analyst Count
- TUYA 0
- ANIP 7
- Target Price
- TUYA N/A
- ANIP $77.33
- AVG Volume (30 Days)
- TUYA 6.3M
- ANIP 172.8K
- Earning Date
- TUYA 02-26-2025
- ANIP 02-28-2025
- Dividend Yield
- TUYA 1.45%
- ANIP N/A
- EPS Growth
- TUYA N/A
- ANIP N/A
- EPS
- TUYA N/A
- ANIP N/A
- Revenue
- TUYA $280,969,000.00
- ANIP $555,456,000.00
- Revenue This Year
- TUYA $30.25
- ANIP $25.54
- Revenue Next Year
- TUYA $18.77
- ANIP $20.95
- P/E Ratio
- TUYA N/A
- ANIP N/A
- Revenue Growth
- TUYA 33.25
- ANIP 23.60
- 52 Week Low
- TUYA $1.28
- ANIP $52.50
- 52 Week High
- TUYA $4.63
- ANIP $70.81
- Technical
- Relative Strength Index (RSI)
- TUYA 77.36
- ANIP 46.25
- Support Level
- TUYA $2.87
- ANIP $58.37
- Resistance Level
- TUYA $3.25
- ANIP $60.54
- Average True Range (ATR)
- TUYA 0.40
- ANIP 1.69
- MACD
- TUYA 0.07
- ANIP -0.21
- Stochastic Oscillator
- TUYA 75.13
- ANIP 20.28
About TUYA Tuya Inc. each representing one
Tuya Inc is an IoT cloud development platform with a mission to build an IoT developer ecosystem and enable everything to be smart. The Company has pioneered a purpose-built IoT cloud development platform that delivers a full suite of offerings, including platform-as-a-service (PaaS) and Software-as-a-service (SaaS), to businesses and developers. Through its IoT cloud development platform, It has enabled developers to activate a vibrant IoT ecosystem of brands, OEMs, partners, and end users to engage and communicate through a broad range of smart devices. The company's revenue is derived from the PRC.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.